In Diagnostics
In Diagnostics is pioneering advancements in blood testing by miniaturizing and integrating blood tests onto a microchip. Their technology leverages microchip capabilities to extract exponentially more information from a single drop of blood, following a 'Moore's Law of blood testing' where the information extracted doubles every three years. The company's approach includes clinical chemistries using a high-precision, multi-color spectrophotometer, immunoassays with magnetic particle technology for quantitative results, and AI-enabled digital hematology. Initially targeting research and veterinary markets, their product line includes tests like Quic BUN+CRE, Quic ALT+AST, Quic ALT, Quic BUN, Quic AST, and Quic CRE. The company is founded on over 20 years of development in microchip-based Point-of-Care devices.
In Diagnostics
In Diagnostics is pioneering advancements in blood testing by miniaturizing and integrating blood tests onto a microchip. Their technology leverages microchip capabilities to extract exponentially more information from a single drop of blood, following a 'Moore's Law of blood testing' where the information extracted doubles every three years. The company's approach includes clinical chemistries using a high-precision, multi-color spectrophotometer, immunoassays with magnetic particle technology for quantitative results, and AI-enabled digital hematology. Initially targeting research and veterinary markets, their product line includes tests like Quic BUN+CRE, Quic ALT+AST, Quic ALT, Quic BUN, Quic AST, and Quic CRE. The company is founded on over 20 years of development in microchip-based Point-of-Care devices.